These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 31195049)

  • 1. The MELAS mutation m.3243A>G alters the expression of mitochondrial tRNA fragments.
    Meseguer S; Navarro-González C; Panadero J; Villarroya M; Boutoual R; Sánchez-Alcázar JA; Armengod ME
    Biochim Biophys Acta Mol Cell Res; 2019 Sep; 1866(9):1433-1449. PubMed ID: 31195049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ROS-sensitive microRNA-9/9* controls the expression of mitochondrial tRNA-modifying enzymes and is involved in the molecular mechanism of MELAS syndrome.
    Meseguer S; Martínez-Zamora A; García-Arumí E; Andreu AL; Armengod ME
    Hum Mol Genet; 2015 Jan; 24(1):167-84. PubMed ID: 25149473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The MELAS mutation m.3243A>G promotes reactivation of fetal cardiac genes and an epithelial-mesenchymal transition-like program via dysregulation of miRNAs.
    Meseguer S; Panadero J; Navarro-González C; Villarroya M; Boutoual R; Comi GP; Armengod ME
    Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):3022-3037. PubMed ID: 29928977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mt tRFs, New Players in MELAS Disease.
    Meseguer S; Rubio MP
    Front Physiol; 2022; 13():800171. PubMed ID: 35273517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction of the consequences of mitochondrial 3243A>G mutation in the MT-TL1 gene causing the MELAS syndrome by tRNA import into mitochondria.
    Karicheva OZ; Kolesnikova OA; Schirtz T; Vysokikh MY; Mager-Heckel AM; Lombès A; Boucheham A; Krasheninnikov IA; Martin RP; Entelis N; Tarassov I
    Nucleic Acids Res; 2011 Oct; 39(18):8173-86. PubMed ID: 21724600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. microRNA-mediated differential expression of TRMU, GTPBP3 and MTO1 in cell models of mitochondrial-DNA diseases.
    Meseguer S; Boix O; Navarro-González C; Villarroya M; Boutoual R; Emperador S; García-Arumí E; Montoya J; Armengod ME
    Sci Rep; 2017 Jul; 7(1):6209. PubMed ID: 28740091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Codon-specific translational defect caused by a wobble modification deficiency in mutant tRNA from a human mitochondrial disease.
    Kirino Y; Yasukawa T; Ohta S; Akira S; Ishihara K; Watanabe K; Suzuki T
    Proc Natl Acad Sci U S A; 2004 Oct; 101(42):15070-5. PubMed ID: 15477592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquisition of the wobble modification in mitochondrial tRNALeu(CUN) bearing the G12300A mutation suppresses the MELAS molecular defect.
    Kirino Y; Yasukawa T; Marjavaara SK; Jacobs HT; Holt IJ; Watanabe K; Suzuki T
    Hum Mol Genet; 2006 Mar; 15(6):897-904. PubMed ID: 16446307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection rates and phenotypic spectrum of m.3243A>G in the MT-TL1 gene: a molecular diagnostic laboratory perspective.
    Chin J; Marotta R; Chiotis M; Allan EH; Collins SJ
    Mitochondrion; 2014 Jul; 17():34-41. PubMed ID: 24846800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in the Caenorhabditis elegans orthologs of human genes required for mitochondrial tRNA modification cause similar electron transport chain defects but different nuclear responses.
    Navarro-González C; Moukadiri I; Villarroya M; López-Pascual E; Tuck S; Armengod ME
    PLoS Genet; 2017 Jul; 13(7):e1006921. PubMed ID: 28732077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MELAS syndrome: Clinical manifestations, pathogenesis, and treatment options.
    El-Hattab AW; Adesina AM; Jones J; Scaglia F
    Mol Genet Metab; 2015; 116(1-2):4-12. PubMed ID: 26095523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short peptides from leucyl-tRNA synthetase rescue disease-causing mitochondrial tRNA point mutations.
    Perli E; Fiorillo A; Giordano C; Pisano A; Montanari A; Grazioli P; Campese AF; Di Micco P; Tuppen HA; Genovese I; Poser E; Preziuso C; Taylor RW; Morea V; Colotti G; d'Amati G
    Hum Mol Genet; 2016 Mar; 25(5):903-15. PubMed ID: 26721932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human mitochondrial leucyl-tRNA synthetase corrects mitochondrial dysfunctions due to the tRNALeu(UUR) A3243G mutation, associated with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like symptoms and diabetes.
    Li R; Guan MX
    Mol Cell Biol; 2010 May; 30(9):2147-54. PubMed ID: 20194621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of cybrids harboring MELAS mutations in the mitochondrial tRNA(Leu(UUR)) gene.
    Koga Y; Davidson M; Schon EA; King MP
    Muscle Nerve Suppl; 1995; 3():S119-23. PubMed ID: 7603512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accumulation of mtDNA with a mutation at position 3271 in tRNA(Leu)(UUR) gene introduced from a MELAS patient to HeLa cells lacking mtDNA results in progressive inhibition of mitochondrial respiratory function.
    Hayashi J; Ohta S; Takai D; Miyabayashi S; Sakuta R; Goto Y; Nonaka I
    Biochem Biophys Res Commun; 1993 Dec; 197(3):1049-55. PubMed ID: 8280119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial haplotype mutation alleviates respiratory defect of MELAS by restoring taurine modification in tRNA with 3243A > G mutation.
    Ueda S; Yagi M; Tomoda E; Matsumoto S; Ueyanagi Y; Do Y; Setoyama D; Matsushima Y; Nagao A; Suzuki T; Ide T; Mori Y; Oyama N; Kang D; Uchiumi T
    Nucleic Acids Res; 2023 Aug; 51(14):7480-7495. PubMed ID: 37439353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defective Expression of the Mitochondrial-tRNA Modifying Enzyme GTPBP3 Triggers AMPK-Mediated Adaptive Responses Involving Complex I Assembly Factors, Uncoupling Protein 2, and the Mitochondrial Pyruvate Carrier.
    Martínez-Zamora A; Meseguer S; Esteve JM; Villarroya M; Aguado C; Enríquez JA; Knecht E; Armengod ME
    PLoS One; 2015; 10(12):e0144273. PubMed ID: 26642043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary coenzyme Q10 deficiency triggers mitochondria degradation by mitophagy in MELAS fibroblasts.
    Cotán D; Cordero MD; Garrido-Maraver J; Oropesa-Ávila M; Rodríguez-Hernández A; Gómez Izquierdo L; De la Mata M; De Miguel M; Lorite JB; Infante ER; Jackson S; Navas P; Sánchez-Alcázar JA
    FASEB J; 2011 Aug; 25(8):2669-87. PubMed ID: 21551238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MELAS phenotype associated with m.3302A>G mutation in mitochondrial tRNA(Leu(UUR)) gene.
    Goto M; Komaki H; Saito T; Saito Y; Nakagawa E; Sugai K; Sasaki M; Nishino I; Goto Y
    Brain Dev; 2014 Feb; 36(2):180-2. PubMed ID: 23582502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Termination of damaged protein repair defines the occurrence of symptoms in carriers of the m.3243A > G tRNA(Leu) mutation.
    van Eijsden RG; Eijssen LM; Lindsey PJ; van den Burg CM; de Wit LE; Rubio-Gozalbo ME; de Die CE; Ayoubi T; Sluiter W; de Coo IF; Smeets HJ
    J Med Genet; 2008 Aug; 45(8):525-34. PubMed ID: 18456717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.